WO2001045688A3 - Use od desloratadine for treating allergic and inflammatory conditions in pediatric patients - Google Patents
Use od desloratadine for treating allergic and inflammatory conditions in pediatric patients Download PDFInfo
- Publication number
- WO2001045688A3 WO2001045688A3 PCT/US2000/034418 US0034418W WO0145688A3 WO 2001045688 A3 WO2001045688 A3 WO 2001045688A3 US 0034418 W US0034418 W US 0034418W WO 0145688 A3 WO0145688 A3 WO 0145688A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- desloratadine
- inflammatory conditions
- pediatric patients
- treating allergic
- treating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Otolaryngology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MXPA02006347A MXPA02006347A (en) | 1999-12-21 | 2000-12-19 | Treating allergic and inflammatory conditions. |
EP00986552A EP1239859A2 (en) | 1999-12-21 | 2000-12-19 | Use of desloratadine for treating allergic and inflammatory conditions in pediatric patients |
CA002393837A CA2393837A1 (en) | 1999-12-21 | 2000-12-19 | Use of desloratadine for treating allergic and inflammatory conditions in pediatric patients |
AU22773/01A AU2277301A (en) | 1999-12-21 | 2000-12-19 | Treating allergic and inflammatory conditions |
JP2001546427A JP2003518045A (en) | 1999-12-21 | 2000-12-19 | Use of desloratadine for the treatment of allergic and inflammatory conditions in pediatric patients |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17291199P | 1999-12-21 | 1999-12-21 | |
US60/172,911 | 1999-12-21 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001045688A2 WO2001045688A2 (en) | 2001-06-28 |
WO2001045688A3 true WO2001045688A3 (en) | 2002-05-02 |
Family
ID=22629711
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/034418 WO2001045688A2 (en) | 1999-12-21 | 2000-12-19 | Use od desloratadine for treating allergic and inflammatory conditions in pediatric patients |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1239859A2 (en) |
JP (1) | JP2003518045A (en) |
AU (1) | AU2277301A (en) |
CA (1) | CA2393837A1 (en) |
MX (1) | MXPA02006347A (en) |
WO (1) | WO2001045688A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7405223B2 (en) | 2000-02-03 | 2008-07-29 | Schering Corporation | Treating allergic and inflammatory conditions |
US6863901B2 (en) | 2001-11-30 | 2005-03-08 | Collegium Pharmaceutical, Inc. | Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration |
US6827946B2 (en) * | 2001-12-05 | 2004-12-07 | Collegium Pharmaceutical, Inc. | Compositions containing both sedative and non-sedative antihistamines |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5595997A (en) * | 1994-12-30 | 1997-01-21 | Sepracor Inc. | Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine |
US5900421A (en) * | 1997-02-11 | 1999-05-04 | Sepracor Inc. | Methods and compositions for treating allergic asthma and dermatitis using descarboethoxyloratadine |
WO1999062516A1 (en) * | 1998-06-01 | 1999-12-09 | Schering Corporation | A stabilized antihistamine syrup containing aminopolycarboxylic acid as stabilizer |
-
2000
- 2000-12-19 JP JP2001546427A patent/JP2003518045A/en not_active Withdrawn
- 2000-12-19 CA CA002393837A patent/CA2393837A1/en not_active Abandoned
- 2000-12-19 EP EP00986552A patent/EP1239859A2/en not_active Ceased
- 2000-12-19 MX MXPA02006347A patent/MXPA02006347A/en unknown
- 2000-12-19 AU AU22773/01A patent/AU2277301A/en not_active Abandoned
- 2000-12-19 WO PCT/US2000/034418 patent/WO2001045688A2/en not_active Application Discontinuation
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5595997A (en) * | 1994-12-30 | 1997-01-21 | Sepracor Inc. | Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine |
US5900421A (en) * | 1997-02-11 | 1999-05-04 | Sepracor Inc. | Methods and compositions for treating allergic asthma and dermatitis using descarboethoxyloratadine |
WO1999062516A1 (en) * | 1998-06-01 | 1999-12-09 | Schering Corporation | A stabilized antihistamine syrup containing aminopolycarboxylic acid as stabilizer |
Non-Patent Citations (1)
Title |
---|
"Dictionnaire du Vidal", 1996, EDITIONS DU VIDAL, PARIS, XP002176060 * |
Also Published As
Publication number | Publication date |
---|---|
AU2277301A (en) | 2001-07-03 |
JP2003518045A (en) | 2003-06-03 |
MXPA02006347A (en) | 2002-12-13 |
CA2393837A1 (en) | 2001-06-28 |
WO2001045688A2 (en) | 2001-06-28 |
EP1239859A2 (en) | 2002-09-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL195723A (en) | Use of p53 inhibitors for the preparation of medicament | |
IL209703A0 (en) | Controlled release hydrocodone formulations | |
AU1200501A (en) | Drug delivery catheters that attach to tissue and methods for their use | |
IL144730A (en) | Use of statin drug in the preparation of a medicament and as a medicament for the treatment of diabetic neuropathy | |
WO2004028570A3 (en) | A method for treating severe tinnitus | |
EP1600167A3 (en) | A pyrrolidineacetamide derivative alone in combination for treatment of CNS disorders | |
WO2001078698A3 (en) | Use of ngf-antagonists for the prevention or treatment of chronic visceral pain | |
HK1043048A1 (en) | Combinations of formoterol and mometasone furoate | |
WO2005058233A3 (en) | Methods for treatment of acute pancreatitis | |
HK1042825A1 (en) | Compounds and methods for the treatment of airway diseases and for the delivery of airway drugs | |
IL127572A (en) | Pharmaceutical composition and medicament for nasal administration | |
NO994165L (en) | Use of descarboethoxyloratadine for the manufacture of a medicament for the treatment of urinary incontinence, travel sickness and dizziness | |
CA2401000A1 (en) | Method of treating and diagnosing sleep disordered breathing and means for carrying out the method | |
IL149360A0 (en) | Method and compositions for administering taxanes orally to human patients | |
WO2001045715A3 (en) | Combinations of an adenosine a1 agonist with an opioid and their use in the treatment of pain | |
WO2001045688A3 (en) | Use od desloratadine for treating allergic and inflammatory conditions in pediatric patients | |
CA2396209A1 (en) | The use of mirtazapine for the treatment of sleep disorders | |
EP0799618A3 (en) | Use of alpha1-adrenoreceptor antagonists in the manufacture of a medicament for the prevention and teatment of cancer | |
HUP0303597A3 (en) | Diposable vaginal cannula for the simultaneous administration of drugs in different forms | |
AU2002253785A1 (en) | Catheter and implants for the delivery of therapeutic agents to tissues | |
HUP0200861A3 (en) | Use of n-acetylcysteine for the preparation of a medicament suitable for the intravenous administration to prevent oxidative stress in dialysed patients | |
AU7965000A (en) | Use of analgesics as digestive and medicines for expectorating and transdermal therapeutic system using the same | |
WO2002041841A3 (en) | Compositions for adhesion prevention | |
WO2001021161A3 (en) | Use of desloratadine for treating allergic and inflammatory conditions | |
HUP0203309A3 (en) | Therapeutic combinations of (s)-2-(benzylamino-methyl)-2,3,8,9,-tetrahydro-7h-1,4-dioxino(2,3)-e indol-8-one and neuroleptics for treatment or prevention of phychotic disorders and pharmaceutical compositions containing them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CZ DE DK DM DZ EE ES FI GB GD GE HR HU ID IL IN IS JP KG KR KZ LC LK LR LT LU LV MA MD MG MK MN MX MZ NO NZ PL PT RO RU SE SG SI SK SL TJ TM TR TT TZ UA US UZ VN YU ZA |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 10130763 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2393837 Country of ref document: CA |
|
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 2001 546427 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2000986552 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2002/006347 Country of ref document: MX |
|
WWP | Wipo information: published in national office |
Ref document number: 2000986552 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWR | Wipo information: refused in national office |
Ref document number: 2000986552 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2000986552 Country of ref document: EP |